Market Cap (In CNY)
4.89 Billion
Revenue (In CNY)
754.69 Million
Net Income (In CNY)
180.57 Million
Avg. Volume
376.74 Thousand
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 45.65-79.99
- PE
- -
- EPS
- -
- Beta Value
- 0.451
- ISIN
- CNE1000053G6
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Fei Gao
- Employee Count
- -
- Website
- https://www.alltests.com.cn
- Ipo Date
- 2021-03-25
- Details
- Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and market of in vitro diagnostic reagents worldwide. It offers rapid diagnostic products, including women's health, infectious diseases, drugs, cancer, cardiovascular, and other five series of products. The company is based in Hangzhou, China.
More Stocks
-
BAF
-
688050
-
FQVTFFevertree Drinks PLC
FQVTF
-
GDLNF
-
000547Addsino Co., Ltd.
000547
-
EXXRFExor N.V.
EXXRF
-
MVI
-
BQSTBioQuest Corp.
BQST